Stevanato Group & Bormioli Pharma Sign Collaboration Agreement

Stevanato Group, through Ompi, its specialist in glass primary packaging for the pharmaceutical industry, and Bormioli Pharma recently announced a collaboration agreement that will enable biopharma customers, contract filling organizations, and research laboratories to receive Bormioli Pharma’s proprietary primary containers in Ompi’s industry-recognized EZ-fill secondary packaging configuration.

Bormioli Pharma is a leading Italian pharma primary packaging manufacturer. With seven manufacturing plants and a wide international commercial network, Bormioli Pharma operates in close partnership with the pharmaceutical industry and with all the businesses that are engineering the future of healthcare. The company serves the pharma and biopharmaceutical markets with integrated glass and plastic packaging solutions, always with one single goal in mind: to put health in the hands of the world.

Bormioli Pharma glass vials supplied in Ompi’s packaging configurations can be processed into existing fill-finish lines. EZ-fill secondary packaging is designed to mitigate the risk of breakages, cosmetic issues, and particulate generation. It is the ideal solution from lab-scale manual filling up to the traditional filling process, allowing to accelerate the commercialization of pharmaceutical and biologics.

Andrea Zambon, Marketing & Product Management Director at Stevanato Group, said “It is with great pride that we announce the agreement with Bormioli Pharma. EZ-fill technology has over the years become the market standard and the reference in secondary packaging. Lean processes, flexibility, and ease of use are EZ-fill key pillars, responding to the market’s rising demand for cost-efficient, scalable solutions. Customers can now count on an additional established player for the supply of ready-to-use parenteral vials.”

Andrea Sentimenti, Marketing&Innovation Manager at Bormioli Pharma, added “As a partner of the pharma industry, we strive every day to go beyond the product, building dedicated services around it. The agreement with Stevanato Group is one more step forward in this direction and allows us to combine the high quality of our parenteral vials with the reliability of EZ-fill technology. The result is a premium packaging solution for parenteral drugs, engineered to overcome the challenges of the most demanding injectables. ”

Established in 1949, Stevanato Group is the world’s largest, privately-owned designer and producer of glass primary packaging for the pharmaceutical industry. From its outset, the Group has developed its own glass converting technology to ensure the highest standards of quality. The Group comprises a wide set of capabilities dedicated to serving the biopharmaceutical and diagnostic industries: from glass containers with its historical brand Ompi, to high-precision plastic diagnostic and medical components, to contract manufacturing for drug delivery devices, to vision inspection systems, assembly, and packaging equipment.

The Group also provides analytical and testing services to study container closure integrity and integration into drug delivery devices, streamlining the drug development process. Thanks to its unique approach as a one-stop-shop, Stevanato Group is able to offer an unprecedented set of solutions to biopharma companies for a faster time to market and a reduced total cost of ownership. For more information, please visit www.stevanatogroup.com.